Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 9 0
Plerixafor Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 2 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 14
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 13
Cefpiramide Potential treatment - theoretical effect Experimental Antiviral Jan/29/2021 2 0
HP-OVA Potential treatment - pre-clinical evidence Experimental Antiviral Jan/14/2021 1 0
Erythrosine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/13/2021 1 0
Methylene blue Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/13/2021 2 0
Colossolactone VIII Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021 1 0